Spending on prescription drugs for autoimmune diseases has increased by 459% over the past decade, even surpassing cancer drugs. Yet despite driving around 30% of employers’ entire prescription spend, autoimmune diseases have remained completely overlooked in employer health spend.
About eight in 10 employers think drug costs, high-cost claims and hospital prices are a “significant threat to affordability,” according to a new survey from National Alliance of Healthcare Purchaser Coalitions.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
When asked what the biggest threats facing them were, 94% of employers said high-cost pharmacy claims, 91% said medical inflation and 91% said million dollar treatments being approved by the FDA, according to a new survey from the Midwest Business Group on Health.
In a recent analysis, the Kaiser Family Foundation estimated that 21 percent of employers offering health benefits will have at least one plan which applies for the tax.
Eden Health opened its first onsite health clinic at Convene's newest and largest co-working location in New York City and plans to open 25 locations across the co-working company's footprint over the next 18 months.
The Affordable Care Act requires employer-sponsored group health plans to cover pre-existing conditions for all individuals regardless of prior coverage.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The Amazon-Berkshire-J.P. Morgan healthcare venture launched last year and headed up by Atul Gawande has a website and finally a name: Haven.
My educated guesses on where the payer market is headed in a rapidly changing healthcare landscape.